Kymriah Data Shows Sustained Remission In Kids, Young Adults
Novartis’ Kymriah created history five years ago when it became the first gene therapy to be licenced in the United States. As Novartis has attempted...
Seqirus, North Carolina Gets Fill Finish Expansion of $156mn
Seqirus recently completed a $156 million expansion plan at its Holly Springs, North Carolina, fill-finish production plant, which began in 2018. The expanded facility,...
GARDP Helps Bugworks Assess New Antibiotics Effectiveness
The Global Antibiotic Research and Development Partnership- GARDP and Bugworks are working together on research to determine the safety profile of a novel class of broad-spectrum...
ACHEMA 2022 addresses the industry’s key issues digitalisation and sustainability
In addition to the transformation towards a climate-neutral chemical industry and the perennial topic of digitalisation, the current global political situation also poses massive...
GSK Unveils Its Transformation Through New Branding And Logo
The British Big Pharma has launched an innovative rebranding, a tech-flavoured logo, and an impactful transformation for the future as GlaxoSmithKline turns GSK and...
Vazkepa From Amarin Gets Recommended By NICE In The U.K
Amarin has earned a much-needed triumph internationally after faltering in the crucial US market. Vazkepa has been approved by the National Institute for Health...
After Lupin Deal Teva Holds Another Austedo Rival To 2033
Teva can rest easy knowing that it does have a long runway free of generics—at least from two major challengers—as it focuses on the...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...